amylin glp 1 dual agonist Frontiers Amycretin vs Semaglutide: Next-Gen Dual
Description
2018;3:e000219
[DOI] [PMC free article] [PubMed] [Google Scholar] 9.Lim G., Brubaker P
[12] [13] Diagnosis involves excluding other conditions that might explain the symptoms, with basic investigations such as full blood count, inflammatory markers (ESR/CRP), thyroid function, and vitamin D levels often considered
Drug names in the diabetes space are notoriously confusing
GLP-1 based therapies: clinical implications for gastroenterologists
doi: 10.1007/s00125-005-1878-0
